Should I have regularly scheduled or on-demand clotting factor replacement therapy for hemophilia?

References

Citations

1. Hillman RS, et al. (2005). Hemophilia and other intrinsic pathway defects. In RS Hillman, et al. eds., Hematology in Clinical Practice, 4th ed., chap. 32, pp. 368–379. New York: McGraw-Hill.

2. Shapiro AD, et al. (2001). Defining the impact of hemophilia: The Academic Achievement in Children with Hemophilia study. Pediatrics, 108(6): 1–6.

Author:	Robin Parks, MS	Last Updated: August 20, 2007
Medical Review:	Anne C. Poinier, MD - Internal Medicine Brian Leber, MDCM, FRCPC - Hematology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.